DRUG DISPOSITION IN OBESE HUMANS - AN UPDATE

被引：153

作者：

ABERNETHY, DR

GREENBLATT, DJ

机构：

[1] TUFTS UNIV,SCH MED,DIV CLIN PHARMACOL,BOSTON,MA 02111

[2] NEW ENGLAND MED CTR,BOSTON,MA 02111

来源：

关键词：

D O I：

10.2165/00003088-198611030-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：199 / 213

页数：15

共 75 条

[1] IBUPROFEN DISPOSITION IN OBESE INDIVIDUALS
ABERNETHY, DR
GREENBLATT, DJ
[J]. ARTHRITIS AND RHEUMATISM, 1985, 28 (10): : 1117 - 1121
[2] THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM
ABERNETHY, DR
GREENBLATT, DJ
DIVOLL, M
SMITH, RB
SHADER, RI
[J]. CLINICAL PHARMACOKINETICS, 1984, 9 (02) : 177 - 183
[3] PROLONGATION OF DRUG HALF-LIFE DUE TO OBESITY - STUDIES OF DESMETHYLDIAZEPAM (CLORAZEPATE)
ABERNETHY, DR
GREENBLATT, DJ
DIVOLL, M
SHADER, RI
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) : 942 - 944
[4] ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[5] ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
[6] CAFFEINE DISPOSITION IN OBESITY
ABERNETHY, DR
TODD, EL
SCHWARTZ, JB
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (01) : 61 - 66
[7] OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION
ABERNETHY, DR
DIVOLL, M
GREENBLATT, DJ
AMEER, B
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) : 783 - 790
[8] ABERNETHY DR, 1984, CLIN PHARMACOL THER, V35, P224
[9] ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[10] LIDOCAINE DISPOSITION IN OBESITY
ABERNETHY, DR
GREENBLATT, DJ
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) : 1183 - 1186